Approval · Notice of Compliance 14507 · 2013
INSTANYL: Notice of Compliance 14507
Issued June 28, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14507
- Date
- June 28, 2013
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Opioid analgesic
Products in this notice
Medicinal ingredients
- FENTANYL CITRATE 50 MCG per DOSE
- FENTANYL CITRATE 100 MCG per DOSE
- FENTANYL CITRATE 200 MCG per DOSE